Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0082 | 0.0189 | 0.0388 |
Brugia malayi | Muscleblind-like protein | 0.018 | 0.2448 | 0.4834 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0286 | 0.4863 | 1 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0082 | 0.0189 | 0.0356 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0082 | 0.0189 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.3002 | 0.3002 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0305 | 0.5294 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0286 | 0.4863 | 1 |
Echinococcus granulosus | geminin | 0.0205 | 0.3002 | 0.6133 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0286 | 0.4863 | 1 |
Brugia malayi | glutathione reductase | 0.0286 | 0.4863 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0286 | 0.4863 | 1 |
Echinococcus multilocularis | muscleblind protein | 0.018 | 0.2448 | 0.5001 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0082 | 0.0189 | 0.0388 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0082 | 0.0189 | 0.0388 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0305 | 0.5294 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0286 | 0.4863 | 1 |
Brugia malayi | Thioredoxin reductase | 0.0286 | 0.4863 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0287 | 0.4895 | 1 |
Toxoplasma gondii | thioredoxin reductase | 0.0286 | 0.4863 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0082 | 0.0189 | 0.5 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0305 | 0.5294 | 1 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0082 | 0.0189 | 0.0388 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0082 | 0.0189 | 0.5 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0252 | 0.4087 | 0.772 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0082 | 0.0189 | 1 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0287 | 0.4895 | 1 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0082 | 0.0189 | 0.0385 |
Mycobacterium tuberculosis | Probable reductase | 0.0252 | 0.4087 | 0.772 |
Loa Loa (eye worm) | glutathione reductase | 0.0286 | 0.4863 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0082 | 0.0189 | 1 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0252 | 0.4087 | 0.772 |
Echinococcus granulosus | muscleblind protein | 0.018 | 0.2448 | 0.5001 |
Echinococcus multilocularis | muscleblind protein 1 | 0.018 | 0.2448 | 0.5001 |
Treponema pallidum | NADH oxidase | 0.0082 | 0.0189 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0082 | 0.0189 | 0.5 |
Echinococcus multilocularis | geminin | 0.0205 | 0.3002 | 0.6133 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0082 | 0.0189 | 0.0385 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0082 | 0.0189 | 0.0388 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0252 | 0.4087 | 0.772 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0082 | 0.0189 | 0.0388 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0082 | 0.0189 | 0.5 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0305 | 0.5294 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0286 | 0.4863 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0286 | 0.4863 | 0.9185 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0252 | 0.4087 | 0.772 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0082 | 0.0189 | 0.0189 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0082 | 0.0189 | 1 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0082 | 0.0189 | 0.5 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0252 | 0.4087 | 0.772 |
Trypanosoma brucei | trypanothione reductase | 0.0286 | 0.4863 | 1 |
Leishmania major | trypanothione reductase | 0.0286 | 0.4863 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.3002 | 0.3002 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 11.9061 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] | ChEMBL. | No reference |
Potency (binding) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.